Hepatobiliary Malignancies

You have full text access to this OnlineOpen article

Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans†

  1. Hashem B. El-Serag1,2,‡,*,
  2. Eric A. Engels3,
  3. Ola Landgren3,
  4. Elizabeth Chiao1,2,
  5. Louise Henderson1,2,
  6. Harshinie C. Amaratunge1,2,
  7. Thomas P. Giordano1,2

Article first published online: 2 SEP 2008

DOI: 10.1002/hep.22606

Issue

Hepatology

Hepatology

Volume 49, Issue 1, pages 116–123, January 2009

Additional Information

How to Cite

El-Serag, H. B., Engels, E. A., Landgren, O., Chiao, E., Henderson, L., Amaratunge, H. C. and Giordano, T. P. (2009), Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology, 49: 116–123. doi: 10.1002/hep.22606

Author Information

  1. 1

    Department of Medicine, Baylor College of Medicine, Houston, TX

  2. 2

    Houston Center for Quality of Care and Utilization Studies, Health Services Research and Development Service, Department of Veterans Affairs Medical Center, Houston, TX

  3. 3

    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD

  1. ‡

    fax:713 748 7359

*Houston VA Medical Center (152), 2002 Holcombe Boulevard, Houston, TX 77030

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 28 DEC 2008
  2. Article first published online: 2 SEP 2008
  3. Accepted manuscript online: 2 SEP 2008 12:00AM EST
  4. Manuscript Accepted: 24 AUG 2008
  5. Manuscript Received: 29 FEB 2008

Funded by

  • Intramural Program of the National Cancer Institute, National Institutes of Health
  • Michael E. DeBakey Veterans Affairs Medical Center, Department of Veterans Affairs, Houston, TX
  • NIH. Grant Number: K24 DK078154-01

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (222K)

References

  • 1
    Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705–714.
  • 2
    Dominitz JA, Boyko EJ, Koepsell TD, Heagerty PJ, Maynard C, Sporleder JL, et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. HEPATOLOGY 2005; 41: 88–96.
    Direct Link:
  • 3
    Perumal V, Wang J, Thuluvath P, Choti M, Torbenson M. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol 2006; 37: 1211–1216.
  • 4
    Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, Callea F, et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 2001; 12: 959–964.
  • 5
    Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, et al. Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000; 88: 2471–2477.
    Direct Link:
  • 6
    Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, Choi HC, et al. Hepatitis B and C virus, Clonorchis sinensis for the risk 52 of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 1996; 25: 933–940.
  • 7
    Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, et al. Hepatitis C virus infection as a likely etiology of 55 intrahepatic cholangiocarcinoma. Cancer Sci 2004; 95: 592–595.
    Direct Link:
  • 8
    Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, et al. Risk factors for intrahepatic and 57 extrahepatic cholangiocarcinoma in the United States: a population-based case-control 58 study. Clin Gastroenterol Hepatol 2007; 5: 1221–1228.
  • 9
    Sorensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjaer L, Linet M, et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 1998; 28: 921–925.
    Direct Link:
  • 10
    Alvares-Da-Silva MR, Francisconi CF, Waechter FL. Acute hepatitis C complicated by pancreatitis: another extrahepatic manifestation of hepatitis C virus? J Viral Hepatol 2000; 7: 84–86.
    Direct Link:
  • 11
    Katakura Y, Yotsuyanagi H, Hashizume K, Okuse C, Okuse N, Nishikawa K, et al. Pancreatic involvement in chronic viral hepatitis. World J Gastroenterol 2005; 11: 3508–3513.
  • 12
    Yoffe B, Bagri AS, Tran T, Dural AT, Shtenberg KM, Khaoustov VI. Hyperlipasemia associated with hepatitis C virus. Dig Dis Sci 2003; 48: 1648–1653.
  • 13
    Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007; 297: 2010–2017.
  • 14
    Fisher SG, Weber L, Goldberg J, Davis F. Mortality ascertainment in the veteran population: alternatives to the National Death Index. Am J Epidemiol 1995; 141: 242–250.
  • 15
    Page WF, Mahan CM, Kang HK. Vital status ascertainment through the files of the Department of Veterans Affairs and the Social Security Administration. Ann Epidemiol 1996; 6: 102–109.
  • 16
    Davila JA, Weston A, Smalley W, El-Serag HB. Utilization of screening for hepatocellular carcinoma in the United States. J Clin Gastroenterol 2007; 41: 777–782.
  • 17
    Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24: 115–125.
  • 18
    Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004; 40: 472–477.
  • 19
    Chen RF, Li ZH, Zou SQ, Chen JS. Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2005; 4: 71–74.
  • 20
    Torbenson M, Yeh MM, Abraham SC. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis. Am J Surg Pathol 2007; 31: 1410–1413.
  • 21
    Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 2007; 102: 1016–1021.
    Direct Link:
  • 22
    Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998; 75: 347–354.
    Direct Link:
  • 23
    Kramer JR, Davila JA, Miller ED, Richardson P, Giordano TP, El-Serag HB. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther 2008; 27: 274–282.
    Direct Link:
  • 24
    Harris RE, Hebert JR, Wynder EL. Cancer risk in male veterans utilizing the Veterans Administration medical system. Cancer 1989; 64: 1160–1168.
    Direct Link:
  • 25
    Namboodiri KK, Harris RE. Hematopoietic and lymphoproliferative cancer among male veterans using the Veterans Administration Medical System. Cancer 1991; 68: 1123–1130.
    Direct Link:
View Full Article (HTML) Get PDF (222K)